ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00190736
Recruitment Status : Completed
First Posted : September 19, 2005
Last Update Posted : November 6, 2007
Sponsor:
Information provided by:
Eli Lilly and Company